<DOC>
	<DOCNO>NCT01160991</DOCNO>
	<brief_summary>Patients suffer schizophrenia high risk become obese develop diabetes . Risk obesity particularly high new schizophrenia drug , clozapine olanzapine . These drug call atypical drug exert action part occupy receptor serotonin , particularly 5HT2A receptor subtype . This receptor may also interfere glucose metabolism insulin action . The purpose study compare atypical antipsychotic drug , olanzapine , act occupy 5HT2A receptor , another antipsychotic drug , amisulpride , mainly act dopamine pathway . Healthy volunteer recruit asked take single dose drug placebo separate day . Then , combine glucose clamp study perform order test effect drug insulin sensitivity insulin secretion .</brief_summary>
	<brief_title>Effect Atypical Antipsychotic Drugs Olanzapine Amisulpride Glucose Metabolism</brief_title>
	<detailed_description>10 male healthy volunteer recruit . After informed consent , admit study ward 10:00 p.m. prior study day keep fast next morning . At 8:00 a.m. receive study medication ( olanzapine , amisulpride placebo ) . Subsequently , measurement insulin sensitivity insulin secretion perform euglycemic hyperinsulinemic clamp technique follow hyperglycemic clamp .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>healthy male volunteer write informed consent BMI &gt; 30 kg/mÂ² Diabetes mellitus Hypertension Treatment drug interfere lipid glucose metabolism ( e.g . statin , oral antidiabetic drug , glucocorticoid ) History seizure</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>olanzapine</keyword>
	<keyword>atypical antipsychotic drug</keyword>
	<keyword>amisulpride</keyword>
	<keyword>diabetes</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>insulin secretion</keyword>
	<keyword>glucose</keyword>
	<keyword>euglycemic hyperinsulinemic clamp</keyword>
	<keyword>hyperglycemic clamp</keyword>
</DOC>